

Aggreko: Goldman Sachs cuts target price from 2425p to 2125p, while retaining its buy recommendation. Alliance Pharma: FinnCap shifts target price fr...


Temporary power provider Aggreko topped the FTSE Tuesday as a report highlighted the "urgent" need to meet rising energy demands. EnergyUK, which repr...


Insurance giant Standard Life was a strong riser after beating analysts' predictions in the first quarter after delivering strong sales and group asse...


Stocks had trimmed gains and were trading broadly flat by Wednesday lunchtime as markets gave a mixed reaction to weak economic data from Germany with...


Johnson Matthey shares were lifted by Credit Suisse, in which it said the speciality chemical makers is in a better position than its peers in Europe ...


The FTSE 100 was pulling back on Friday morning after four consecutive days of gains as investors turned cautious ahead of a meeting of Eurozone finan...


There will be no upgrades yet for Aggreko after a decent first quarter, but upside risk is building, according to Jefferies which reiterated its 'buy'...


There will be no upgrades yet for Aggreko after a decent first quarter, but upside risk is building, according to Jefferies which reiterated its 'buy'...